Delivery Order SPE2DB20D2104-SPE2DB23FV50V
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the supply of Quillivant XR 25 mg/5 ml suspension (120 ml) to the Defense Logistics Agency (DLA). The $2,860.23 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, which runs through November 2026, enables the efficient procurement of a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,543.32 delivery order contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a 120 ml medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,709.74 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension (120 ml) and has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,409.08 firm fixed-price delivery order is for the drug Quillivant XR 25 mg/5 ml suspension, with a completion date of September 27, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,016.24 firm fixed price delivery order is from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of the drug Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The award falls under an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 held by Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,579.48 Firm Fixed Price Delivery Order is for the supply of Quillivant XR, a 25 mg/5 ml suspension medication, with a period of performance through July 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,548.58 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a specialty medication. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,577.04 delivery order contract is for the supply of Quillivant XR, a 25 mg/5 ml suspension medication, with an ultimate completion date of May 7, 2025. The contract is designated as a firm fixed-price Delivery Order, without any set-aside requirements. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award, valued at $1,524.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Quillivant XR, a 25 mg/5 ml suspension medication, with a completion date of June 23, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC...
- This federal contract award, valued at $4,527.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract to supply 4567966120 - QUILLIVANT XR ORAL SUSP 60ML 5MG/ML, with a period of performance through April 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV50VDelivery Order
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension medication to the Defense Logistics Agency (DLA). The $1,431.62 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is part of that larger IDC and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a critical supplier to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA), leveraging its extensive pharmaceutical distribution capabilities to efficiently fulfill government contracts for essential medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/25/23 |